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ABSTRACT
Abnormalities in quality of life and cognitive measures
have been observed in women with Turner syndrome
(TS), and a relationship between these phenomena and
chromosomal constitution has been suggested. In contrast,
few studies have systematically evaluated the presence of
mood and behavioral syndromes in these women. In this
study, 100 TS women were administered the Structured
Clinical Interview for DSM IV after a two-week period
during which their hormone replacement had been
discontinued. The majority of women who met criteria
for a psychiatric condition had a mood or anxiety disorder.
Overall, 52 (52%) of the TS women met criteria for a
current or a past depressive or anxiety disorder. Eighteen of
the women with TS met criteria for a current Axis I
psychiatric disorder [Depression – major (n=5), minor
(n=5), dysthymia (n=1); Anxiety (n=9)]. Forty-six
of the women with TS met criteria for a past Axis I
psychiatric illness [Depression: unipolar (n=41), bipolar
(n=3); Anxiety (n=7); eating disorder (n=6);
substance dependence (n=3)]. Five women with TS
met criteria for an Axis II personality disorder. Women
with TS reported a higher rate of lifetime depression
compared with rates observed in community-based studies
but similar to those obtained from gynecologic clinic
samples.
INTRODUCTION
The loss of all or part of the 2nd X sex chromosome
during embryogenesis results in Turner syndrome
(TS), or monosomy X. This relatively common
chromosomal disorder affects*1/2500 live female
births, with short stature and hypogonadism the
most common clinical ﬁndings1–3. Anatomical
features such as lymphedema, skeletal abnormalities
and congenital heart and kidney defects are found in
about 50% of affected individuals1,2. Brain devel-
opment also may be affected in TS, with several
neuroimaging studies reporting anatomical and
functional differences between girls or women with
TS and age-matched controls in the parietal and
dorsolateral prefrontal cortices, superior temporal
gyrus, hippocampal formation, amygdala, and
temporal lobes4–8. Supporting the possibility of
brain involvement, girls and women with TS
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demonstrate a distinct neurocognitive proﬁle where
verbal ability is generally normal9–11 while visual-
spatial abilities, working memory and executive
function may be impaired12–15.
While speciﬁc cognitive deﬁcits have been
documented in TS, the prevalence of psychopathol-
ogy in this disorder has only been addressed in a few
small studies. There seems to be a consensus that
many girls with TS exhibit immaturity, poor self-
esteem and difﬁculties with social relationships, and
appear more likely to receive diagnoses of non-
verbal learning disorder and/or ADHD16,17. Skuse
and co-workers have suggested that individuals with
TS have difﬁculty in reading facial expressions
connoting emotions, especially fear (as seen in
autism)18, as well as social problems, and have
related these behavioral traits to both an amygdalar
dysfunction and a maternal origin of the single
normal X-chromosome18–21. Whether these psy-
chological features observed in girls with TS
portend an increased risk of psychiatric diagnoses
in adult life is unclear. The few prior studies16,22,23
showed a broad range of lifetime prevalences of
psychiatric disorders in TS women.
In the present study we have employed structured
diagnostic interviews to establish the prevalence of
DSM-IV diagnoses in a large population of women
with TS from across the United States.
METHODS
Subjects
Women with TS provided written informed
consent/assent for voluntary participation in this
study protocol approved by the National Institute of
Child Health and Human Development (NICHD)
Institutional Review Board. This psychiatric eva-
luation was one component of a primary protocol
that involves a 4–5 day stay in the NIH Clinical
Research Center. All study subjects were pheno-
typic females, at least 16 years of age, with a
diagnosis of TS that was conﬁrmed by a 50-cell
peripheral karyotype in which 4 70% of cells
demonstrated loss of all or part of the 2nd sex
chromosome. Study subjects discontinued the use of
ovarian hormone or growth hormone treatment
two weeks prior to admission (for reasons related to
the primary protocol) and were euthyroid and in
good general health based on laboratory and clinical
evaluations. Study subjects were recruited primarily
through notices on the web and the NIH home
page.
From an initial sample of 112 TS women, nine
were excluded on the grounds of being less than 16
years of age, and three adults declined participation.
One hundred TS women were evaluated with the
Structured Clinical Interview for the Diagnostic and
Statistical Manual of Mental Disorders (fourth
edition) (SCID I & II)24, a structured diagnostic
interview that establishes the presence or absence of
Axis I and II diagnoses. SCID interviews were
administered by GC, RD, NH, and PS.
The number of women with TS meeting criteria
for an Axis I disorder were tabulated. The
percentages of women with TS who met SCID
criteria for current and lifetime (deﬁned as the
occurrence of an Axis I disorder at any time in the
woman’s life) mood and anxiety disorders were
compared with published prevalence rates of these
disorders from several large community-based
studies25–27 and gynecologic clinic-based samples28.
Additionally, in those women with and without a
lifetime affective disorder we examined possible
differences in the number of women who either
received hormonal therapies (thyroid and GH) or
had physical stigmata of TS (i.e., webbing of the
neck or short stature) by Chi square and Student’s t
test (height only). Finally, we compared the number
of women meeting criteria for a lifetime psychiatric
disorder in the women with TS with a 45-X




The mean age of our study group was 34.7+ 11.6
years with a range of 16–61 years (Table 1). The
great majority (91%) were Caucasian with the
remainder consisting of African American, Hispanic
and Asian women; 62% had never married and only
three had children. The group as a whole was highly
functional, with women greater than 22 years old
having an average of 16.3+ 2.1 years of formal
education, while the younger women were gen-
erally in high school or college. Forty women
(40.4%) had webbing of the neck, 32.7% had a
history of past or current treatment with growth
hormone (GH), 33% were currently on thyroid
hormone replacement, and all women received
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some form of HRT (oral contraceptives (58%), the
remaining were on estrogen and progestin therapy).
The women received hormone replacement ther-
apy for an average of 14.6+ 10.7 years. Fourteen
women were currently taking antidepressants. The
karyotype distribution for the 100 women in this
study was approximately: 67% 45,X; 19% 45,X/
46,XX or 46XY (5 30% normal cells); 10%
46,XiXq or 46,XiXq/45,X with5 10% 45,X; 4%
46,XdelXp or 45X/46,XdelXp with a few 45,X/
46,XrX, (ring X condition) all with retained X
inactivation segments.
Psychiatric diagnosis
Forty-eight percent of women did not meet
criteria for any current or past Axis I psychiatric
diagnosis, and only ﬁve women met criteria for an
Axis II (personality) disorder (three of whom also
met criteria for an Axis I condition). Eighteen
percent of women with TS met criteria for a
current Axis I diagnosis: 11% affective disorders
(mainly major depression (5%), minor depression
(5%) and dysthymia (1%)), and 11% anxiety
disorders. Depressive and anxiety disorders coex-
isted in four women. Comparable rates of current
Axis I diagnoses from community-based and
gynecology clinic-based samples of women are
listed in Table 2.
A past Axis I diagnosis was observed in 46% of
women with TS and reﬂected a predominance of
affective disorders (44%), with 33% of women
meeting criteria for a past major depression. A past
history of both affective and anxiety disorders was
present in three women, affective and eating
disorders in ﬁve women, and two women had two
or more Axis I diagnoses.
Lifetime major depression occurred in 36% of
women, and lifetime affective disorders (any mood
disorder) in 47% of women, compared with rates in
the community of 21% and 24%, respectively27 (as
well as 63% [lifetime affective disorders] in one
gynecology clinic-based study29). Lifetime histories
of anxiety disorders were observed in 15% of
women with TS and in 15–30% of women in
community studies.
Table 1 Characteristics of women with Turner
syndrome (n=100), mean (SD)
Turner syndrome (TS)
Age yrs [range] 34.7 (11.6) [16–61]
Marital status (% single) 62
Caucasian (%) 91
Height (cm) 146.2 (10.0)
BMI 27.6 (6.5)
Education (yrs) 15.5 (2.7)
No. on BCP/HRT 56/40*
Duration of HRT (yrs) 14.6 (10.7)
No. on GH 32**
No. on thyroid H 33
No. on antidepressants 14
No. with webbing of neck 40§
Free testosterone 6.8 (4.3) pg/ml
No. with children 9 (3 biological, 6 adopted)
*data missing in four women
**data missing in two women
§data missing in one woman










Affective disorders 11 (7%)* 44
Major depression 5 (3–6%)
[6%]
33
Minor depression 5 8
Dysthymia 1 0
Bipolar disorder 0 3
Anxiety disorders 11 (10%) [7%] 7
Panic disorder 4 1
Social phobia 2 (1–4%) 0
Generalized anxiety disorder 2 0
Speciﬁc phobia 2 1
Anxiety disorder NOS 1 0
PTSD 0 5
Eating disorder 0 6
Anorexia 0 5
Bulimia 0 1
Substance dependence 0 3




*Published rates of current Axis I diagnosis appear in
rounded parentheses ( ) from community samples25–27
and in square parentheses [ ] from gynecology clinic
samples28
{46% of women with TS did not meet SCID criteria for
current or past Axis I or II psychiatric diagnosis
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Comparison between TS women with and
without lifetime affective disorders showed no
differences in the presence of webbing of the neck
(Chi-square = 0.08, p=NS), history of treatment
with GH (Chi-square = 0.9, p=NS), and current
treatment with thyroid hormone (Chi-square = 0.9,
p=NS). Additionally, height did not signiﬁcantly
differ in those women with and without an affective
disorder (Students t99 = 0.2, p=NS).
DISCUSSION
This study represents the largest case series focusing
on the psychiatric status of women with TS. Our
major ﬁndingwas thatwomenwithTSdonot report
substantially higher rates of current psychiatric
disorders including depression or anxiety disorders,
compared to published community-based preva-
lence rates. A higher lifetime rate of mood disorders
(butnotpsychiatricdisorders ingeneral)wasobserved
in women with TS compared to that reported in
community-based samples, but comparable to that
observed in gynecology clinic-based samples.
Recently there has been considerable attention
focused on improving the quality of life in women
with TS. Enhanced social and family support
networks and treatment with growth hormone
and estrogen with or without androgen replacement
therapies early in the course of TS may contribute to
an improved quality of life. However, the presence
and impact of co-existing psychiatric morbidity has
received little attention. Indeed, neuro-imaging
studies in women with TS have identiﬁed abnorm-
alities in several brain regions relative to controls
including the dorsolateral prefrontal cortex, amyg-
dala, and hippocampus4,7,30–33. The function of
these brain regions also has been reported to be
altered in mood disorders34,35, and, therefore, the
neuroimaging data would suggest that women with
TS may have an increased risk for the development
of affective disorders. In this study, the number of
women with TS who met criteria for a current Axis
I psychiatric illness was comparable to reported rates
of women in several community-based25–27 and
gynecology clinic-based28,29 samples. Speciﬁcally,
rates of current mood and anxiety disorders were
not substantially increased in women with TS
despite discontinuing hormone replacement ther-
apy for the two weeks prior to the interview. The
rate of lifetime psychiatric diagnoses was almost twice
as high in women with TS compared to commu-
nity-based samples and reﬂected a higher rate of
mood but not anxiety disorders in these women.
However, both the current and lifetime rates of
mood disorders were not substantially higher than
those previously reported in either medical out-
patient36,37 or gynecology clinics29. Thus, our data
would suggest that TS is not associated with an
increased risk of depressive illness, beyond that
expected to occur in association with any medical or
gynecologic condition.
Three previous studies have evaluated the pre-
sence of psychiatric diagnoses in women with TS.
Delooz et al.22 administered a structured diagnostic
interview to 20 women with TS and observed rates
of lifetime psychiatric illness of 50% (the majority of
which were mood disorders) and current mood
disorders of 20%. Albeit in a substantially smaller
sample, the data of Delooz et al. are comparable to
our ﬁndings. In contrast two other studies reported
lower and higher rates of psychiatric illness,
respectively. McCauley et al. observed a 22%
lifetime prevalence of psychiatric illness in a sample
of 27 women with TS38. The small sample size and
the absence of a structured diagnostic interview may
account for the discrepant ﬁndings of this study. In
contrast, Downey et al. administered a structured
diagnostic interview to 23 women with TS drawn
from their private practice and reported a 70%
lifetime prevalence of psychiatric illness23. How-
ever, the higher rate of lifetime psychiatric illness
observed by Downey et al. may reﬂect the selection
of women with more severe mood and behavioral
symptoms present in this practice.
Abnormalities of thyroid function39 and growth
hormone secretion40 both are associated with the
appearance of mood disorders; however, in our
sample there was no increased number of women
treated with either hormone in the women meeting
criteria for a past or current affective disorder
compared to those with no history of psychiatric
illness. Similarly, despite possible associations be-
tween mood symptoms and the physical stigmata of
TS, the presence of a webbing of the neck41,42 or
short stature43,44 was not disproportionately repre-
sented in the women with mood disorders. Finally,
our data did not suggest a difference in the risks for
psychiatric disorders in those TS women with 45X
compared to those with other karyotype abnorm-
alities, including mosaic patterns.
Several observations in women with TS also
suggest that they experience distressing social
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anxiety45. First, clinical reports have documented
that women with TS experience more social anxiety
and shyness than matched controls46, traits proposed
to be on a continuum with some anxiety disorders
such as social phobia47,48. Second, women with TS
have been observed to display deﬁcits in several
social processes including difﬁculty recognizing
facial expressions and determining the direction of
eye gaze. Finally, both structural and functional
neuroimaging studies have identiﬁed alterations in
several brain regions associated with social cognition
and behavior32,49,50 in women with TS compared
to controls including the amygdala, superior
temporal sulcus, and orbitofrontal cortex20. We
observed only two women out of the 100 inter-
viewed who met criteria for social phobia, and only
four additional women met criteria for panic
disorder. Thus our data do not suggest that the
social difﬁculties reported by many women with TS
lead to the syndrome of social phobia or other
anxiety disorders. Moreover, it is remarkable that so
few women with TS met criteria for social phobia
given prior reports of the high rate of shyness and
social anxiety present in women with TS46. Our
data, therefore, would suggest that in the context of
a medical condition like TS, the excessive shyness
and social anxiety does not progress to a clinical
syndrome of social phobia in the vast majority of
women.
Several case reports suggested a higher than
expected prevalence of eating disorders in TS51,52.
In fact, the association between these two condi-
tions was interpreted by some to reﬂect a common
pathophysiology, whereas others suggested the co-
occurrence of these conditions is predicted by their
prevalence rates and chance53,54. None of the
women in this study met criteria for a current
eating disorder. Although the 6% of our sample who
met criteria for a past history of an eating disorder is
higher than the 1% prevalence rate in the general
population55, it approximates that reported in
medical conditions such as diabetes mellitus (up to
8.3%)56. Thus our data would not suggest a speciﬁc
relationship between TS and eating disorders other
than what has been observed in the context of a
general medical condition.
The present ﬁndings represent the largest sample
of women with TS to be evaluated with a structured
diagnostic interview. Our ﬁndings may differ from a
population-based study on TS, since many of the
womenwere self-referred, and our sample may have
been a healthier, more motivated and less shy group
of women. Nonetheless, the comparable rates of
psychiatric conditions in this large sample of women
to those published prevalence rates in gynecology
clinics suggests that the neurobiologic and genetic
abnormalities in TS do not uniquely or uniformly
lead to psychiatric syndromes.
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